中国疫情重来,新冠红利助跑MRNA股价翻升

中国新一波 COVID-19 pandemic comes back,Moderna的 mRNA 疫苗很可能在2023下半年重新成为市场宠儿,MRNA股价@137.75 顺风炒作再涨一波。疫情是人道灾难,也是投资良机。YMYD

China braces for new Covid wave with up to 65 million weekly cases
https://www.cnbctv18.com/world/china-braces-for-new-covid-19-wave-with-up-to-65-million-weekly-cases-16728131.htm

登录后才可评论.